MoneyWorks4Me

The quarter ended September 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 18680.00 millions.Net profit declined -29.77% to Rs. 3420.00 millions from Rs. 4870.00 millions.The Operating Profit of the company witnessed a decrease to 5590.00 millions from 6880.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 18680.00 18230.00 2.47 35980.00 40270.00 -10.65 76253.00 88798.20 -14.13
Other Income 850.00 790.00 7.59 1650.00 1690.00 -2.37 3490.10 1112.60 213.69
PBIDT 5590.00 6880.00 -18.75 11300.00 16150.00 -30.03 26966.90 39877.20 -32.38
Interest 10.00 0.00 0.00 10.00 0.00 0.00 5.20 6.50 -20.00
PBDT 5580.00 6880.00 -18.90 11290.00 16150.00 -30.09 26961.70 39870.70 -32.38
Depreciation 940.00 850.00 10.59 1870.00 1680.00 11.31 3420.70 3105.50 10.15
PBT 4640.00 6030.00 -23.05 9420.00 14470.00 -34.90 23541.00 36765.20 -35.97
TAX 1220.00 1160.00 5.17 2550.00 2690.00 -5.20 5459.50 7279.80 -25.00
Deferred Tax 140.00 260.00 -46.15 240.00 410.00 -41.46 1083.70 907.80 19.38
PAT 3420.00 4870.00 -29.77 6870.00 11780.00 -41.68 18081.50 29485.40 -38.68
Equity 530.00 530.00 0.00 530.00 530.90 -0.17 530.90 530.90 0.00
PBIDTM(%) 29.93 37.74 -20.71 31.41 40.10 -21.69 35.37 44.91 -21.25

Divis Laboratories Share Price

8248.50 -43.05 (-0.52%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: